Articles

JPMorgan Chase CEO Jamie Dimon suggests the half-point interest-rate cut is “a minor thing” that Wall Street — not Main Street — is obsessing over.

That’s in part because most of his $700 million contract is deferred. Still, his stats this season are worth over $50 million to his team.

Micron shares have shed most of their 2024 gains, but memory pricing could improve in the coming months, Citi says.

The dynamics that fueled the meme-stock frenzy have not gone away, according to a new study.

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.

Recent inflation spike — and moderation — underscores its importance

Inflation might actually fall too far, Fed governor says.

Constellation has a new nuclear-power deal with Microsoft. Both Constellation and Vistra shares have more than doubled this year on optimism for data-center power deals.

Small-cap stocks just saw their longest winning streak in three and a half years, after the Federal Reserve recalibrated its monetary policy with a big interest-rate cut. 

Yardeni: Odds of a 1990s-like market boom have increased after Fed rate-cut.

Trump Media & Technology Group Corp.’s stock dropped to its lowest level since it went public in March Friday, as a ban on stock sales lifted.

With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy counter next year need to stay vigilant in the coming months.